HHS sent the White House Office of Management and Budget the proposal, titled “Removal of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection,” July 18. While the rule’s language is hidden from the pubic until the office completes a review, just the publicly available title sent shares sliding. The safe harbor policy is a legal protection that shields drugmaker rebates made to PBMs from anti-kickback statutes.
Although the proposed policy’s language isn’t available, several PBMs felt its effect: Express Scripts Holding shares slid 1.1 percent, CVS Health shares dropped 1.7 percent and UnitedHealth Group shares dropped 1.2 percent.
Read the full report here.
More articles on pharmacy:
Pfizer stock value dips after Trump’s tweet
8 lesser-known facts about Pfizer
Joining Pfizer, Novartis freezes price hikes in US
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.